Eva Guinan is faculty lead of Translational Innovator at Harvard Catalyst. She is director of translational research in the Radiation Oncology Department at Dana-Farber Cancer Institute (DFCI), professor of radiation oncology at Harvard Medical School (HMS), and adjunct faculty in medicine at Boston Children’s Hospital (BCH). Her translational research program focuses on defining, expanding and administering immunomodulatory cell populations with the goal of overcoming problems related to allogenicity and regimen-related toxicity in transplantation. She also studies how innovation happens in the biomedical space and how it can be improved, leading to her role as co-director of the Laboratory for Innovation Science at Harvard (LISH). Previously, she served as director of the Pediatric Bone Marrow Transplant Service at BCH/DFCI. She received her MD from HMS, completed a pediatric residency at BCH, and a pediatric hematology-oncology fellowship at BCH and DFCI.
